Dr. Fink is a popular and in-demand Miami area physician, and is Medical Director of the Miami Center of Excellence (Miami, FL), and Florida Keys OB/GYN (Key Largo, FL). His areas of expertise include sexual medicine and sexual function optimization, bio-identical hormones and menopause management, contraception, sexually transmitted infections, menstrual dysfunction, and fertility. Named amongst "America's Top OB/GYNs", "Who's Who in Obstetrics & Gynecology", Dr. Fink has received the Patient's Choice Award for over half a decade, and prides himself on the superlative, personal care he provides.Dr. Fink is a well known consultant to both print and television media on women's health and general health topics. He is most proficient in translating complicated scientific and medical subjects into easily understood sound bytes, and with his extensive prior expertise in the entertainment industry, Dr. Fink is uniquely talented in both live studio television and on-camera medical reporting.He is also a sought after expert witness to the judicial system on topics related to his medical specialty. A mastery of the scope of practice, Dr. Fink can testify as to standards for office & hospital obstetrics, surgical techniques, OB & GYN ultrasound, gynecology office practice, and certain cosmetic procedures. He is frequently retained by both defense and plaintiff's attorneys.View the profile
Kayla Fioravanti is an award-winning author, cosmetic formulator, aromatherapy educator, and researcher of all things hemp. She has been an advocate for small businesses to Congress, the FDA, and worked along side large and small business associations for fair cosmetic regulations. She co-founded a company in her kitchen for $50 in 1998 and built it into a certified organic, cGMP compliant, and fast growing company which she sold for millions in 2011. Kayla is the author of “A Little Handbook about Topical CBD: A Revolutionary Ingredient for the Skincare World” and Hemp CBD 101″ as well as 11 other books.View the profile
Dr. Manison’s experience with CBD is rather unique. The benefit he experienced was tighter blood sugar control. Although he was already in great shape, he found that the CBD somehow lowered blood sugar levels and he could reduce his insulin dosage. He researched this intriguing result and found that the ECS, acting as the master homeostatic mechanism of the body, was likely better regulating the anti-insulin hormones of the body: primarily glucagon, epinephrine, and cortisol. Although this is his experience and he, of course, cannot tout this benefit to others as it is his individual experience and his experience is anecdotal, he did begin collecting hundreds of medically indexed studies that discuss CBD and its effect on the body. Now he wishes to bring this necessary information to all of you to help you be as healthy as you can be. In his practice, Dr. Manison believes in addressing the structural, chemical, and mental aspects of our health. A properly functioning ECS is of utmost importance to not only a reduction in pain and inflammation on the structural side, but also to a properly functional mental side through the CB1 receptors.View the profile
The founder of the Upward Cannabis Kitchen, Carlton has a passion for crafting high quality cannabis products. Through the development of a tea based cannabis beverage line, Carlton was able to explore ancillary endocannabinoid modulators and the wide world of botanicals and brings this passion into their work as a cook, consultant, and caregiver. When not developing personalized formulations, Carlton helps their mother – Dr. Melanie Bone – with her cannabis wellness practice in South Florida. With the list time remaining, Carlton enjoys volunteering with a local Harm Reduction Group and making art and wonderful memories with friends.View the profile
James Schwartz BSN, LNC, is an experienced medical legal consultant and CEO of CascadeHigh Organics with 20years experience cultivating legal cannabis. James is a self-described organic minimalist cultivating in the most sustainable manner. James believes in clean Cannabis and its use as a wellness drug. His Oregon licensed cultivation has been featured in Dope Magazine, Oregon Leaf Magazine, and has articles in both publications as well. James is a former member of NCIA Cultivation Committee and has presented at multiple Cannabis and CBD conferences all over the country. James was a drafter and is a signature on the written testimony to the FDA and congress on behalf of NCIA for CBD policy. His business, legal, medical, and agricultural knowledge provides a comprehensive perspective on the cannabis industry. James has lobbied for Cannabis on both the national and state level with Oregon Cannabis Association and is a fierce advocate for the plant and cannabinoid therapeutics.View the profile
About the talk
In the age of the opioid epidemic, the rising number of mental health drugs being prescribed, and a surge in methamphetamine usage nation-wide, we are encouraged by recent data that shows the potential of CBD to act as a cannabinoid-based therapy. Cannabidiol has been shown to modulate the endocannabinoid system in such a way that it helps to fight addiction on a cellular level. Cannabinoids represent a promising avenue in the treatment of substance use disorder because of their wide therapeutic range and very low potential for toxicity. The discussion will focus on current scientific understanding and future direction of research.
00:17 Making cannabis treatments more accessible
07:04 Should cannabis be a substitute for opioids?
19:20 Medical professionals education programs
21:55 Problem with cannabis therapeutic
Included in subscription
To start things off. I think we can all recognize the opiates for me in the predominant strategy in chronic pain management because of their accessibility affordability and acceptability. What can CBD manufacturers clinicians’ researchers do to help lower these barriers to access and decrease the stigma associated with cannabis treatments. So we are just now bringing our CBD line of products out. Previously were we were focused just on THC cannabis products in Oregon. But if you're familiar with the Cannabis Market in Oregon, we have a massive oversupply problem. And so
trying to sell weed has become very difficult in Oregon. So give companies want to succeed you're looking at ways that you can Branch out of that market. So we're bringing CBD lines on and we've contracted with a pain management physician in North Carolina who's begun to use CBD in his practice and has started some early data-gathering. We're about to retool their product lines and also bring on some competing product lines to see the sort of results that we can get. But as we know
in 2015, they looked at a retroactive study and they looked at the 30 at the time the 33 states that allow cannabis and what they Download 30% fewer opiate prescriptions 30% fewer overdose deaths and a loss of 186 million dollars to the pharmaceutical industry. So the farm is interested in this too. I think that's in a GW